Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
867 Embedding partial SBRT in low-dose radiotherapy (EclipseRT) plus immune checkpoint inhibitors for bulky tumors: a preclinical and clinical study
Compose a Response to This Article
Other responses
No responses have been published for this article.
